A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity-Reference-Cited by-同舟云学术

A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity

Published:2021-03-01 Issue:2 Volume:29 Page:166-174
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Ahn Jae-Hee¹,Lee Byung-Hyun²,Kim Seong-Eun¹,Kwon Bo-Eun¹,Jeong Hyunjin¹,Choi Jong Rip³,Kim Min Jung³,Park Yong²,Kim Byung Soo²,Kim Dae Hee³,Ko Hyun-Jeong¹⁴

Affiliation:

1. Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea

2. Scripps Korea Antibody Institute, Kangwon National University, Chuncheon 24341, Republic of Korea

3. Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea

4. Kangwon Institute of Inclusive Technology, Kangwon National University, Chuncheon 24341, Republic of Korea

Funder

Ministry of Science, ICT, and Future Planning

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2021/029/BT029-02-06.pdf

Reference31 articles.

1. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody

2. Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

3. Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy

4. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

5. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complex interplay between Mitochondria-Associated Membranes (MAMs) and cardiovascular Inflammation: Molecular mechanisms and therapeutic implications;International Immunopharmacology;2024-11

2. Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care;Cancers;2024-03-14

3. Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8⁺ T cell infiltration in melanoma;Cancer Science;2024-01-22

4. RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect;Cells;2023-08-03

5. Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells;Nature Communications;2023-05-05